Eli Lilly has won the second FDA approval for an oral selective estrogen receptor degrader (SERD). | Eli Lilly has won the second FDA approval for an oral selective estrogen receptor degrader (SERD), ...

With a late-stage win in hand, Sweden’s Hansa Biopharma is one step closer to bringing its kidney transplant drug to the U.S. | Hansa Biopharma has reported positive topline results from a U.S. phase ...

AstraZeneca is throwing one last Hail Mary following a string of Big Pharma defeats challenging the legality of the Inflation ...

Starting in January, the newly launched BMS Patient Connect platform will offer Sotyktu at a discount of more than 80% off ...

Belén Garijo, who steered Merck KGaA through the COVID-19 pandemic, will step down as CEO of the German healthcare and electronics conglomerate. | Belén Garijo, who steered Merck KGaA through the ...

Moderna has opened the doors to its long-anticipated Harwell vaccine production facility in the U.K., reaffirming its ...

Guardant Health is joining in on the American Lung Association’s (ALA’s) push to raise awareness about lung cancer screening ...

Just over 42% of those surveyed said their companies are already running a DTP program, while another 30% said they’re ...

Soleno Therapeutics is breathing easier with a report from Acadia Pharmaceuticals that its candidate to treat hyperphagia in ...

Excitement around Fujifilm Biotechnologies’ massive new cell culture facility in Holly Springs, North Carolina, has been ...

Generics of Gilead Sciences' twice-yearly HIV pre-exposure prophylaxis (PrEP) Yeztugo (lenacapavir) are on the horizon, with ...

In his attempts to reduce drug prices in the U.S., President Donald Trump’s message to the rest of the world has been clear: ...